Oxiblume:CoQ10 Therapy for Chronic Prostatitis and Pelvic Pain
Official title: Oxiblume:CoQ10 (Ralivia) Therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): a Double-blind Placebo-controlled Randomized Clinical Trial Assessing Treatment Efficacy and Safety.
Run by G.Gennimatas General Hospital · NCT07629505 · Data updated 2026-11-12
A double-blind, placebo-controlled test to see if Oxiblume:CoQ10 helps people aged 18–50 with Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Men only |
| Enrollment | 100 (estimated) |
| Sponsor | G.Gennimatas General Hospital Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Thessaloniki) |
| Status | Recruiting |
| Started | June 8, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT07629505 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–50 with a clinical CP/CPPS diagnosis and pain for at least three months within the last six months.
✕Probably not a fit
Patients with certain urinary infections, prior urological cancers, prior pelvic treatments, or other conditions in the exclusion list may not benefit and could be unlikely to respond.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial tests the efficacy and safety of Oxiblume:CoQ10 (Ralivia) versus placebo in adults with CP/CPPS. It is a randomized, double-blind, placebo-controlled design to minimize bias and assess symptom relief and tolerability. Participants must have at least three months of pelvic or perineal pain within the past six months and meet specific health criteria. The study is coordinated by the Research Office of the 1st Urology Department at G. Gennimatas General Hospital in Thessaloniki. Outcome measures and detailed methods are not fully provided here, but the design follows standard phytotherapy approaches with emphasis on safety and repeatability of treatment cycles.
Why it matters
Potential benefit: If successful, patients may experience reduced pelvic pain and improved quality of life with a therapy that is cost-effective and potentially repeatable.
How similar studies have gone: Phytotherapy approaches have shown promise in CP/CPPS, but results are variable and prior studies have limitations; this trial adds a rigorous randomized design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participant must be between 18 and 50 years old. 2. Participant has signed and dated the appropriate Informed Consent document. 3. Participant has had a clinical diagnosis of CP/CPPS defined as symptoms of discomfort or pain in the perineal or pelvic region for at least a three (3) month period within the last six (6) months. Exclusion Criteria: 1. Participant has evidence of facultative Gram negative or enterococcus with a value of ≥ 1000 CFU/ml in mid-stream urine (VB2). 2. Participant has a history of prostate, bladder or urethral cancer. 3. Participant has undergone pelvic radiation or systemic chemotherapy. 4. Participant has undergone intravesical chemotherapy. 5. Participant has unilateral orchialgia without pelvic symptoms, active urethral stricture or bladder stones, or any other urological condition associated with LUTS, any neurological disease or disorder affecting the bladder. 6. Participant has undergone prostate surgery or treatment. 7. Participant with penile or urinary sphincter implants. 8. Participant has been diagnosed with cancer during the last 5 years or had any surgery in the pelvis. 9. Participant has a neurological impairment or psychiatric disorder preventing his understanding of consent and his ability to comply with the protocol.
Where it's running
-
G.Gennimatas General Hospital
Thessaloniki, Greece Recruiting
Study contacts
- Study coordinator: IOANNIS MYKONIATIS, Professor
- Email: g_mikoniatis@hotmail.com
- Phone: +306936975862
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Kinesiophobia, Activity, Sleep, and Quality of Life in Women With Chronic Pelvic Pain
This study tests how fear of movement relates to activity, sleep, and overall quality of life in women with chronic pelvic pain compared to healthy women.
-
Exploring ozone therapy for chronic pelvic pain in women with gynecological cancers
This study is testing whether ozone therapy can help relieve chronic pelvic pain in women with gynecological cancers after their cancer treatments.
-
Remote pelvic floor yoga program for chronic pelvic pain
This study tests whether a remote yoga program can help women with chronic pelvic pain feel better compared to a regular physical conditioning program.
-
Genetic analysis of chronic pelvic pain conditions
This study is trying to find out if certain genes are linked to chronic pelvic pain by collecting samples from people with the condition and their families.
-
Immune profile test for women with chronic pelvic pain and endometriosis
This study tests a functional immune test to see if immune profiles differ in women with chronic pelvic pain and endometriosis who aren’t responding to first-line treatments.
-
Comparing two methods for pudendal nerve block in pelvic pain treatment
This study is testing two different ways to give a nerve block to see which one helps women with pelvic pain feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.